Cargando…
BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307748/ https://www.ncbi.nlm.nih.gov/pubmed/35869049 http://dx.doi.org/10.1038/s41420-022-01111-4 |
_version_ | 1784752833090813952 |
---|---|
author | Marola, Olivia J. Yablonski, Sarah E. R. Shrager, Peter G. Nickells, Robert W. Libby, Richard T. |
author_facet | Marola, Olivia J. Yablonski, Sarah E. R. Shrager, Peter G. Nickells, Robert W. Libby, Richard T. |
author_sort | Marola, Olivia J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9307748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93077482022-07-24 BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury Marola, Olivia J. Yablonski, Sarah E. R. Shrager, Peter G. Nickells, Robert W. Libby, Richard T. Cell Death Discov Comment Nature Publishing Group UK 2022-07-22 /pmc/articles/PMC9307748/ /pubmed/35869049 http://dx.doi.org/10.1038/s41420-022-01111-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Comment Marola, Olivia J. Yablonski, Sarah E. R. Shrager, Peter G. Nickells, Robert W. Libby, Richard T. BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury |
title | BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury |
title_full | BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury |
title_fullStr | BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury |
title_full_unstemmed | BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury |
title_short | BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury |
title_sort | bclx(l) (bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307748/ https://www.ncbi.nlm.nih.gov/pubmed/35869049 http://dx.doi.org/10.1038/s41420-022-01111-4 |
work_keys_str_mv | AT marolaoliviaj bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury AT yablonskisaraher bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury AT shragerpeterg bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury AT nickellsrobertw bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury AT libbyrichardt bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury |